Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Galapagos doses first patient in EQUATOR study of filgotinib

April 6, 2017

Bristol-Myers Squibb presents prodrug of BMT-1438 for the treatment of rheumatoid arthritis

April 5, 2017

Galapagos to study filgotinib in Sjogren's syndrome, ankylosing spondylitis and psoriatic arthritis

April 4, 2017

FDA clears Audentes Therapeutics' IND for AT-132

April 4, 2017

First patient dosed in phase I trial of JHL-1101 in rheumatoid arthritis

March 30, 2017

Replicel's phase I/II tendon repair study of RCT-01 meets primary endpoint

March 29, 2017

Xeljanz approved in Europe

March 28, 2017

European Commission approves Amgen's adalimumab biosimilar Amgevita

March 24, 2017

Takeda presents new toll-like receptor inhibitors

March 22, 2017

Healthy subjects receive JNJ-63823539, a new TNF-alpha and IL-17A bispecific antibody

March 22, 2017

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...